Company Overview

Ondine Biopharma Inc. (Ondine) is a preclinical stage pharmaceutical company engaged in the development and commercialization of novel therapies for oral infectious disease.

Ondine is currently involved in the development of a proprietary technology for treating infections using light-activated drugs.

Ondine is currently in preclinical development of the PACT technology and anticipates entering human clinical trials in both the UK and the United States during 2001. Based on the current development plans, a PACT product for treating periodontal disease could be on the market within the next four to five years.

During the commercial development and regulatory approval of PACT for periodontal disease, Ondine intends to expand its product portfolio to include other medical applications of PACT, as well as acquiring new platform technologies for the treatment of infectious disease.

Company Information

Additional Details

Legal Name: Ondine Biopharma Corporation

Number of Employees: 5

Contacts

Products

• Pharmaceuticals

NAICS Categories

• 414510 Pharmaceuticals and Pharmacy Supplies Wholesaler-Distributors

Additional Information